Pharmaceuticals

Custom Antibody Services Market was valued at US$ 590.33 Million in 2023 and is expected to reach US$ 1,216.35 Million by 2031; it is estimated to record a CAGR of 9.5% from 2023 to 2031

• Life Sciences
• Pharmaceuticals

Custom Antibody Services Market was valued at US$ 590.33 Million in 2023 and is expected to reach US$ 1,216.35 Million by 2031; it is estimated to record a CAGR of 9.5% from 2023 to 2031

Market News Insights April 3, 2025

Custom antibodies are essential to personalized therapies, as they can be designed to target specific molecular markers...

Read More Read more about Custom Antibody Services Market was valued at US$ 590.33 Million in 2023 and is expected to reach US$ 1,216.35 Million by 2031; it is estimated to record a CAGR of 9.5% from 2023 to 2031

Europe Intra-Articular Injection for Osteoarticular Infiltrations Market was valued at US$ 97.43 Million in 2023 and is expected to reach US$ 157.08 Million by 2031; it is estimated to record a CAGR of 6.2% from 2023 to 2031

• Life Sciences
• Pharmaceuticals

Europe Intra-Articular Injection for Osteoarticular Infiltrations Market was valued at US$ 97.43 Million in 2023 and is expected to reach US$ 157.08 Million by 2031; it is estimated to record a CAGR of 6.2% from 2023 to 2031

Market News Insights April 2, 2025

As more people seek to manage their joint pain and improve their quality of life, intra-articular injections...

Read More Read more about Europe Intra-Articular Injection for Osteoarticular Infiltrations Market was valued at US$ 97.43 Million in 2023 and is expected to reach US$ 157.08 Million by 2031; it is estimated to record a CAGR of 6.2% from 2023 to 2031

Bacterial Vaginosis Drug Market was valued at US$ 2.15 Billion in 2024 and is expected to reach to US$ 3.82 Billion by 2031; it is estimated to record a CAGR of 8.3% from 2024 to 2031

• Pharmaceuticals

Bacterial Vaginosis Drug Market was valued at US$ 2.15 Billion in 2024 and is expected to reach to US$ 3.82 Billion by 2031; it is estimated to record a CAGR of 8.3% from 2024 to 2031

Market News Insights March 19, 2025

Rising prevalence of bacterial vaginosis, and the increased focus on developing novel and targeted therapies are contributing...

Read More Read more about Bacterial Vaginosis Drug Market was valued at US$ 2.15 Billion in 2024 and is expected to reach to US$ 3.82 Billion by 2031; it is estimated to record a CAGR of 8.3% from 2024 to 2031

Enteral Nutrition Market was valued at US$ 10,584.80 Million in 2024 and is expected to reach US$ 17,330.87 Million by 2031; it is estimated to record a CAGR of 7.3% from 2025 to 2031

• Life Sciences
• Pharmaceuticals

Enteral Nutrition Market was valued at US$ 10,584.80 Million in 2024 and is expected to reach US$ 17,330.87 Million by 2031; it is estimated to record a CAGR of 7.3% from 2025 to 2031

Market News Insights March 18, 2025

North America accounted for a major share of the global enteral nutrition market in 2022. Factors propelling...

Read More Read more about Enteral Nutrition Market was valued at US$ 10,584.80 Million in 2024 and is expected to reach US$ 17,330.87 Million by 2031; it is estimated to record a CAGR of 7.3% from 2025 to 2031

Sickle Cell Disease Treatment Market was valued at US$ 1,160.16 Million in 2022 and is expected to reach to US$ 4,691.87 Million by 2030; it is estimated to record a CAGR of 19.1% from 2022 to 2030

• Pharmaceuticals

Sickle Cell Disease Treatment Market was valued at US$ 1,160.16 Million in 2022 and is expected to reach to US$ 4,691.87 Million by 2030; it is estimated to record a CAGR of 19.1% from 2022 to 2030

Market News Insights February 24, 2025

Extending Pipeline of New Drugs and Vaccines The R&D of new medicines is considered the best strategy...

Read More Read more about Sickle Cell Disease Treatment Market was valued at US$ 1,160.16 Million in 2022 and is expected to reach to US$ 4,691.87 Million by 2030; it is estimated to record a CAGR of 19.1% from 2022 to 2030

Radiopharmaceuticals Market was valued at US$ 9.07 Billion in 2023 and is expected to reach to US$ 26.51 Billion by 2031; it is estimated to record a CAGR of 14.4% from 2023 to 2031

• Pharmaceuticals

Radiopharmaceuticals Market was valued at US$ 9.07 Billion in 2023 and is expected to reach to US$ 26.51 Billion by 2031; it is estimated to record a CAGR of 14.4% from 2023 to 2031

Market News Insights February 20, 2025

Nuclear medicine is a field that is undergoing many changes. As radiopharmaceuticals evolve rapidly, more advanced diagnostic...

Read More Read more about Radiopharmaceuticals Market was valued at US$ 9.07 Billion in 2023 and is expected to reach to US$ 26.51 Billion by 2031; it is estimated to record a CAGR of 14.4% from 2023 to 2031

Epilepsy Market was valued at US$ 7.7 Billion in 2022 and is expected to reach to US$ 10.7 Billion by 2030; it is estimated to record a CAGR of 4.1% from 2022 to 2030

• Pharmaceuticals

Epilepsy Market was valued at US$ 7.7 Billion in 2022 and is expected to reach to US$ 10.7 Billion by 2030; it is estimated to record a CAGR of 4.1% from 2022 to 2030

Market News Insights February 19, 2025

Epilepsy is one of the most common chronic neurological disorders across the world. Associated with an abnormal...

Read More Read more about Epilepsy Market was valued at US$ 7.7 Billion in 2022 and is expected to reach to US$ 10.7 Billion by 2030; it is estimated to record a CAGR of 4.1% from 2022 to 2030

Epilepsy Drugs Market was valued at US$ 7,768.50 Million in 2022 and is expected to reach to US$ 10,705.48 Million by 2030; it is estimated to record a CAGR of 29.7% from 2022 to 2030

• Pharmaceuticals

Epilepsy Drugs Market was valued at US$ 7,768.50 Million in 2022 and is expected to reach to US$ 10,705.48 Million by 2030; it is estimated to record a CAGR of 29.7% from 2022 to 2030

Market News Insights February 12, 2025

Increasing Product Approvals Would Lead to Future Trends in Market In recent years, there has been a...

Read More Read more about Epilepsy Drugs Market was valued at US$ 7,768.50 Million in 2022 and is expected to reach to US$ 10,705.48 Million by 2030; it is estimated to record a CAGR of 29.7% from 2022 to 2030

Radiopharmaceutical Therapeutic Market was valued at US$ 2.71 Billion in 2023 and is expected to reach to US$ 7.30 Billion by 2031; it is estimated to record a CAGR of 13.1% from 2023 to 2031

• Pharmaceuticals

Radiopharmaceutical Therapeutic Market was valued at US$ 2.71 Billion in 2023 and is expected to reach to US$ 7.30 Billion by 2031; it is estimated to record a CAGR of 13.1% from 2023 to 2031

Market News Insights February 10, 2025

Radiopharmaceuticals precisely target and deliver high doses of radiation directly to the site of the disease. The...

Read More Read more about Radiopharmaceutical Therapeutic Market was valued at US$ 2.71 Billion in 2023 and is expected to reach to US$ 7.30 Billion by 2031; it is estimated to record a CAGR of 13.1% from 2023 to 2031

Human Vaccine Adjuvants Market was valued at US$ 1,571.41 Million in 2022 and is expected to reach to US$ 4,489.23 Million by 2030; it is estimated to record a CAGR of 14.0% from 2022 to 2030

• Pharmaceuticals

Human Vaccine Adjuvants Market was valued at US$ 1,571.41 Million in 2022 and is expected to reach to US$ 4,489.23 Million by 2030; it is estimated to record a CAGR of 14.0% from 2022 to 2030

Market News Insights February 3, 2025

North America accounted for the largest share of the global human vaccine adjuvants market in 2022, and...

Read More Read more about Human Vaccine Adjuvants Market was valued at US$ 1,571.41 Million in 2022 and is expected to reach to US$ 4,489.23 Million by 2030; it is estimated to record a CAGR of 14.0% from 2022 to 2030